{"transactions":[{"id":962101,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-19T11:38:13.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/19/2025 and will vest 100% on the one-year anniversary of the grant date (December 18, 2026) or immediately prior to the next Annual General Meeting, whichever is sooner."}],"balance_after":2711,"derivative":{"exercise_price":1.29,"expiration_date":"2030-12-18","underlying":"Common shares","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001213900-25-123620","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390025123620/ownership.xml","form_type":"4"}},{"id":965169,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Expiration)","published_at":"2025-12-17T12:20:20.000Z","date":"2025-12-15","kind":"other","planned":false,"acquired":false,"shares":14,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00"}],"balance_after":961,"derivative":{"exercise_price":1397.97,"exercise_date":"2020-12-16","expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":14},"source":{"system":"sec-edgar","filing":"0001213900-25-122649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390025122649/ownership.xml","form_type":"4"}},{"id":1287538,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Expiration)","published_at":"2025-02-03T08:49:05.000Z","date":"2025-01-11","kind":"other","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$4,125.00 using an exchange rate of C$1.4422 = $US1.00"}],"balance_after":975,"derivative":{"exercise_price":2860.21,"exercise_date":"2020-01-12","expiration_date":"2025-01-11","underlying":"Common shares","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001213900-25-009136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390025009136/ownership.xml","form_type":"4"}},{"id":1322920,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-23T09:17:37.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split."}],"balance_after":977,"derivative":{"exercise_price":4.14,"expiration_date":"2029-12-19","underlying":"Common shares","underlying_shares":550},"source":{"system":"sec-edgar","filing":"0001213900-24-111543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390024111543/ownership.xml","form_type":"4"}},{"id":1597087,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Expiration)","published_at":"2024-03-05T15:20:52.000Z","date":"2024-01-14","kind":"other","planned":false,"acquired":false,"shares":42,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$412.50 using an exchange rate of C$1.3436 = $US1.00"}],"balance_after":8542,"derivative":{"exercise_price":307.01,"exercise_date":"2019-01-14","expiration_date":"2024-01-14","underlying":"Common shares","underlying_shares":42},"source":{"system":"sec-edgar","filing":"0001213900-24-020088","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390024020088/ownership.xml","form_type":"4"}},{"id":1625535,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-22T13:38:46.000Z","date":"2024-02-21","kind":"purchase","planned":false,"acquired":true,"shares":37500,"price":0.39,"value":14625.0,"ownership":{"direct":true},"balance_after":38258,"source":{"system":"sec-edgar","filing":"0001213900-24-016026","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390024016026/ownership.xml","form_type":"4"}},{"id":1700185,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-26T13:04:18.000Z","date":"2023-12-23","kind":"grant","planned":false,"acquired":true,"shares":7100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner."}],"balance_after":8584,"derivative":{"exercise_price":0.37,"expiration_date":"2028-12-22","underlying":"Common shares","underlying_shares":7100},"source":{"system":"sec-edgar","filing":"0001213900-23-098486","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390023098486/ownership.xml","form_type":"4"}},{"id":2081834,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T16:51:19.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":1484,"derivative":{"exercise_price":1.78,"expiration_date":"2027-12-15","underlying":"Common shares","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001213900-22-080959","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390022080959/ownership.xml","form_type":"4"}},{"id":2427878,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Expiration)","published_at":"2022-01-24T16:17:49.000Z","date":"2022-01-24","kind":"other","acquired":false,"shares":30303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$3.63 using an exchange rate of C$1.2554 = $US1.00"}],"balance_after":16122,"derivative":{"exercise_price":2.89,"exercise_date":"2016-09-12","expiration_date":"2022-01-24","underlying":"Common shares","underlying_shares":30303},"source":{"system":"sec-edgar","filing":"0001213900-22-003331","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390022003331/ownership.xml","form_type":"4"}},{"id":2456273,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-30T18:02:20.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/29/2021 and will vest 100% on the one year anniversary of the grant date (Dec 29, 2022) or immediately prior to the next AGM, whichever is sooner."}],"balance_after":46425,"derivative":{"exercise_price":1.32,"expiration_date":"2026-12-28","underlying":"Common shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001213900-21-068184","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390021068184/ownership.xml","form_type":"4"}},{"id":2938166,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71098,"kind":"person","name":"HULL ANDREW","position":1,"cik":"0001818252","reported_name":"HULL ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-18T06:20:37.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner."}],"balance_after":7000,"derivative":{"exercise_price":3.02,"expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001213900-20-043366","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818252/000121390020043366/ownership.xml","form_type":"4"}}]}